All In Biotech

Drug Trial Radar · NCT04179734

Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

Physiological Study to Determine the Role of the Melanocortin-4 Receptor in Brain Activity in Women With Hypoactive Sexual Desire Disorder

Last checked: Nov 19, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Oct 7, 2019

Primary completion

Oct 6, 2020

Study completion Oct 6, 2020

Sponsor

Lead sponsor
Imperial College Healthcare NHS TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
AMAG Pharmaceuticals, Inc.
First posted
Nov 27, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomised, double-blind, placebo-controlled, two-way crossover physiological study. Designed to evaluate the effects of melanocortin-4 receptor (MC4R) activation on brain activity patterns and behavioural psychometric measures of sexual arousal during visual erotic stimuli in approximately 40 right-handed, heterosexual, premenopausal women aged 18 years and over with Hypoactive Sexual Desire Disorder (HSDD) for at least a 6 month duration.

Conditions

  • Hypoactive Sexual Desire Disorder

Interventions

  • BremelanotideDrug

    Melanocortin-4 receptor agonist subcutaneous injection.

  • PlaceboDrug

    Placebo subcutaenous injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in Blood Oxygen Level Dependent (BOLD) Signal Change on Functional MRITime frame: Baseline and 15 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Imperial College Healthcare NHS Trust

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.